Humoral, cellular, clinical responses and safety of two doses of SARS-CoV-2 Messenger RNA vaccine in patients with compensated and decompensated cirrhosis: a long-term single center prospective study

Authors :: M. Iavarone
G. Tosetti
F. Facchetti
M. Topa
A. Lombardi
R. D'Ambrosio
E. Degasperi
A. Loglio
C. Oggioni
A. Bandera
A. Gori
F. Ceriotti
L. Scudeller
A. Bertoletti
P. Lampertico
Source :: Digestive and Liver Disease. 54:S1
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools